US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US6749864B2
(en)
*
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
GB2189699A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
US5026560A
(en)
*
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
JPH03504497A
(ja)
*
|
1988-05-25 |
1991-10-03 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
新規フルオルアルコキシ化合物
|
DK399389A
(da)
*
|
1988-08-18 |
1990-02-19 |
Takeda Chemical Industries Ltd |
Injicerbare oploesninger
|
GR1002098B
(en)
*
|
1989-06-08 |
1995-12-28 |
Squibb & Sons Inc |
Pharmaceutical composition having good stability
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
ZA919510B
(en)
*
|
1990-12-05 |
1992-10-28 |
Smithkline Beecham Corp |
Pharmaceutical compositions
|
IT1250701B
(it)
*
|
1991-07-24 |
1995-04-21 |
Angelini Francesco Ist Ricerca |
Composizione farmaceutica solida per uso orale a base di dapiprazolo
|
HU217629B
(hu)
*
|
1991-12-12 |
2000-03-28 |
Novartis Ag. |
Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
|
BR9306702A
(pt)
*
|
1992-07-08 |
1998-12-08 |
Monsanto Co |
Benzimidazóis para aliviar úlceras estomacais em suínos
|
WO1994002140A1
(en)
*
|
1992-07-17 |
1994-02-03 |
Astra Aktiebolag |
Pharmaceutical composition containing antiulcer agent
|
JPH0656665A
(ja)
*
|
1992-08-03 |
1994-03-01 |
Nippon Chemiphar Co Ltd |
イミダゾール誘導体を含有する胃溶性抗潰瘍剤
|
ZA937382B
(en)
*
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
SG45369A1
(en)
*
|
1993-01-19 |
1998-10-16 |
Warner Lambert Co |
Stable oral ci-981 formulation and process of preparing same
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
EP0642797B1
(de)
*
|
1993-09-09 |
2000-05-17 |
Takeda Chemical Industries, Ltd. |
Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
|
KR100353384B1
(ko)
*
|
1993-10-12 |
2002-12-28 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
장용성과립함유정제
|
TW280770B
(de)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5399356A
(en)
*
|
1994-03-24 |
1995-03-21 |
The Procter & Gamble Company |
Process for making solid dose forms containing bismuth
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
CH687810A5
(de)
*
|
1995-05-24 |
1997-02-28 |
Mepha Ag |
Pelletformulierung mit Omeprazol.
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
AU725622B2
(en)
*
|
1995-12-22 |
2000-10-19 |
Kowa Company, Ltd. |
Pharmaceutical composition stabilized with a basic agent
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6090419A
(en)
*
|
1996-05-02 |
2000-07-18 |
Mccormick & Company, Inc. |
Salt compositions and method of preparation
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
CA2204580A1
(en)
*
|
1997-05-06 |
1998-11-06 |
Michel Zoghbi |
Synthesis of pharmaceutically useful pyridine derivatives
|
US6437139B1
(en)
|
1997-05-06 |
2002-08-20 |
Pdi-Research Laboratories, Inc. |
Synthesis of pharmaceutically useful pyridine derivatives
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
CN1141097C
(zh)
*
|
1998-04-20 |
2004-03-10 |
卫材株式会社 |
含有稳定化的苯并咪唑类化合物的组合物
|
CN1195500C
(zh)
|
1998-05-18 |
2005-04-06 |
武田药品工业株式会社 |
可口腔崩解的片剂
|
CA2581111A1
(en)
|
1998-07-28 |
2000-02-10 |
Takeda Pharmaceutical Company Limited |
Rapidly disintegrable solid preparation
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US20040224989A1
(en)
*
|
1999-01-29 |
2004-11-11 |
Barberich Timothy J. |
S-lansoprazole compositions and methods
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
IL130602A0
(en)
*
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
SE9902386D0
(sv)
*
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6780880B1
(en)
*
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
KR100359256B1
(ko)
*
|
1999-10-06 |
2002-11-04 |
한미약품공업 주식회사 |
란소프라졸의 개선된 제조방법
|
PT1222922E
(pt)
|
1999-10-20 |
2007-09-12 |
Eisai R&D Man Co Ltd |
Método para estabilizar compostos de benzimidazole.
|
EP1259238A1
(de)
*
|
1999-11-22 |
2002-11-27 |
Arthur M. Deboeck |
Stabile pharmazeutische zusammensetzung enthaltend ein säureempfindliches benzimidazol
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US6242003B1
(en)
*
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
KR100430575B1
(ko)
*
|
2001-02-21 |
2004-05-10 |
주식회사 씨트리 |
란소프라졸 및 그 중간체의 제조방법
|
US20060127474A1
(en)
*
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
US6800264B1
(en)
|
2001-04-27 |
2004-10-05 |
United States Aluminate Company |
Process for stabilizing aqueous aluminate and zirconate solutions
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
PT1459737E
(pt)
|
2001-10-17 |
2012-11-26 |
Takeda Pharmaceutical |
Grânulos contendo um composto químico instável em meio ácido em concentração elevada
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
KR100464174B1
(ko)
*
|
2002-03-06 |
2005-01-03 |
코오롱유화주식회사 |
설피닐 벤즈이미다졸 유도체의 제조방법
|
EP1492511B3
(de)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
|
MXPA04009979A
(es)
*
|
2002-04-09 |
2004-12-13 |
Flamel Tech Sa |
Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxicilina.
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
KR100873419B1
(ko)
*
|
2002-06-18 |
2008-12-11 |
페어차일드코리아반도체 주식회사 |
높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
ES2294358T3
(es)
|
2002-08-21 |
2008-04-01 |
Teva Pharmaceutical Industries Ltd |
Procedimiento de purificacion de lansoprazol.
|
EP2596792A1
(de)
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stabile, feste Präparate
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
WO2004039728A1
(en)
*
|
2002-10-24 |
2004-05-13 |
United States Aluminate Company |
Process for stabilizing aqueous aluminate and zirconate solutions
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
US7678816B2
(en)
*
|
2003-02-05 |
2010-03-16 |
Teva Pharmaceutical Industries Ltd. |
Method of stabilizing lansoprazole
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
WO2004093875A1
(en)
*
|
2003-04-22 |
2004-11-04 |
Dr. Reddy's Laboratories Limited |
Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these
|
ES2234393B2
(es)
*
|
2003-04-29 |
2006-09-01 |
Laboratorios Belmac, S.A. |
"formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
|
JP2006528181A
(ja)
*
|
2003-07-18 |
2006-12-14 |
サンタラス インコーポレイティッド |
酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
|
AU2004257864A1
(en)
*
|
2003-07-18 |
2005-01-27 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050232992A1
(en)
*
|
2003-09-03 |
2005-10-20 |
Agi Therapeutics Limited |
Proton pump inhibitor formulations, and methods of preparing and using such formulations
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
WO2005076987A2
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
MXPA06009991A
(es)
*
|
2004-03-03 |
2007-04-10 |
Teva Pharma |
Una composicion farmaceutica estable que comprende un farmaco labil acido.
|
CA2557634A1
(en)
*
|
2004-03-04 |
2005-09-15 |
Takeda Pharmaceutical Company Limited |
Stable capsule preparation
|
WO2005117870A2
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
ES2409347T3
(es)
|
2004-10-21 |
2013-06-26 |
Aptalis Pharmatech, Inc. |
Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
WO2006085335A2
(en)
*
|
2005-01-03 |
2006-08-17 |
Lupin Limited |
Pharmaceutical composition of acid labile substances
|
FR2881957B1
(fr)
|
2005-02-16 |
2008-08-08 |
Solvay |
Comprimes comprenant une substance biologiquement active et un excipient
|
US20060210637A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Qpharma, Llc |
Stable tablet dosage forms of proton pump inhibitors
|
US9040564B2
(en)
*
|
2005-04-28 |
2015-05-26 |
Eisai R&D Management Co., Ltd. |
Stabilized composition
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
US20060252830A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Brandon Stephen F |
Method for the treatment of magnesium and potassium deficiencies
|
US20060252831A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Christopher Offen |
Method for the treatment of magnesium and potassium deficiencies
|
FR2885526B1
(fr)
*
|
2005-05-13 |
2007-07-27 |
Flamel Technologies Sa |
Medicament oral a base d'inhibiteur de pompe a protons
|
US20070026071A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Qpharma, Llc |
Magnesium salt proton pump inhibitor dosage forms
|
BRPI0617987A2
(pt)
*
|
2005-10-06 |
2011-08-16 |
Auspex Pharmaceuticals Inc |
composição, composição farmacêutica, forma de dosagem efervescente, composição farmacêutica oral de comprimidos unitários múltiplos, forma de dosagem farmacêutica de liberação prolongada, forma de dosagem farmacêutica revestida entérica, forma de dosagem farmacêutica estável para administração oral a sujeitos mamìferos, método para tratamento de doenças relacionadas a ácido gástrico pela inibição de secreção de ácido gástrico, método para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori, processo para preparar um composto da fórmula 3, processo para preparar um composto da fórmula 5, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relacionadas a ácido gástrico, pela inibição de secreção de ácido gástrico, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relecionadas a ácido gástrico pela inibição de secreção de ácido gástrico
|
WO2007041790A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jon Pty Limited |
Salts of proton pump inhibitors and process for preparing same
|
EP1785135A1
(de)
|
2005-11-10 |
2007-05-16 |
Laboratorios Del Dr. Esteve, S.A. |
Neue Lanzoprazol enthaltende stabilisierte galenische Formulierungen und ihre Herstellung
|
JP2009538901A
(ja)
*
|
2006-06-01 |
2009-11-12 |
デクセル ファーマ テクノロジーズ エルティーディー. |
複式ユニット製薬的製剤
|
EP2023721A2
(de)
*
|
2006-06-05 |
2009-02-18 |
Auspex Pharmaceuticals Inc. |
Herstellung und verwendung substituierter erythromycin-analoge
|
EP2068841B1
(de)
|
2006-10-05 |
2018-09-26 |
Santarus, Inc. |
Neuartige formulierungen von protonenpumpenhemmern und verfahren zu ihrer verwendung
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
EP2478894A3
(de)
|
2006-12-22 |
2012-12-19 |
Ironwood Pharmaceuticals, Inc. |
Zusammensetzungen zur Behandlung von Speiseröhrenerkrankungen
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
AU2008310735B2
(en)
*
|
2007-10-12 |
2013-09-12 |
Takeda Pharmaceutical Company Limited |
Methods of treating gastrointestinal disorders independent of the intake of food
|
JPWO2009069280A1
(ja)
*
|
2007-11-27 |
2011-04-07 |
大原薬品工業株式会社 |
造粒物の製造法
|
CN101980700A
(zh)
|
2008-02-20 |
2011-02-23 |
密苏里大学董事会 |
包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
|
GEP20135845B
(en)
|
2008-03-11 |
2013-06-10 |
Takeda Pharmaceutical |
Orally-disintegrating solid formulation
|
EP2257220B1
(de)
*
|
2008-03-13 |
2017-06-14 |
Liebel-Flarsheim Company LLC |
Fussbetätigte multifunktionssteuerung für bildgebungssystem
|
US20090263475A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Nagaraju Manne |
Dexlansoprazole compositions
|
WO2009136398A2
(en)
*
|
2008-05-06 |
2009-11-12 |
Dexcel Ltd |
Stable benzimidazole formulation
|
SI22806A
(sl)
*
|
2008-06-23 |
2009-12-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nove kristalinične oblike natrijevega rabeprazola
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
EP2445344A4
(de)
*
|
2009-06-25 |
2013-01-23 |
Pozen Inc |
Verfahren zur behandlung eines patienten mit bedarf an einer aspirintherapie
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
AU2010321874A1
(en)
*
|
2009-11-20 |
2012-06-21 |
Handa Pharmaceuticals, Llc |
Oral formulation for dexlansoprazole
|
JP5309262B2
(ja)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
フェキソフェナジン・マイクロカプセル及びそれを含む組成物
|
WO2011085181A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US20110189271A1
(en)
*
|
2010-02-02 |
2011-08-04 |
Vishal Lad |
Pharmaceutical formulations of acid-labile drugs
|
US20130216617A1
(en)
|
2010-06-29 |
2013-08-22 |
Cadila Healthcare Limited |
Pharmaceutical compositions of (r)-lansoprazole
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
US9399064B2
(en)
*
|
2011-04-12 |
2016-07-26 |
Sawai Pharmaceutical Co., Ltd. |
Pitavastatin-containing preparation and method for producing same
|
CN104519888A
(zh)
|
2011-12-28 |
2015-04-15 |
波曾公司 |
用于递送奥美拉唑和乙酰水杨酸的改良组合物和方法
|
JP6716255B2
(ja)
|
2013-01-15 |
2020-07-01 |
アイロンウッド ファーマシューティカルズ,インコーポレーテッドIronwood Pharmaceuticals, Inc. |
胆汁酸捕捉剤の胃内滞留型徐放性経口剤形
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
EP3288556A4
(de)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Oral zerfallende zusammensetzungen
|
CN104817492B
(zh)
*
|
2015-05-22 |
2018-05-18 |
抚州三和医药化工有限公司 |
兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基)吡啶的分离纯化方法
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
EP3544614A4
(de)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
Orale testosteron-undecanoat-therapie
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|